Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion

BACKGROUND: A glycoproteomic study has previously shown cadherin-5 (CDH5) to be a serological marker of metastatic breast cancer when both protein levels and glycosylation status were assessed. In this study we aimed to further validate the utility of CDH5 as a biomarker for breast cancer progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fry, Simon A, Robertson, Claire E, Swann, Ruth, Dwek, Miriam V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984911/
https://www.ncbi.nlm.nih.gov/pubmed/27010749
http://dx.doi.org/10.1038/bjc.2016.66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984911/
https://www.ncbi.nlm.nih.gov/pubmed/27010749
http://dx.doi.org/10.1038/bjc.2016.66

Ejemplares similares